Edarbi 40 mg/1
Azilsartan kamedoxomil · TABLET · Azurity Pharmaceuticals, Inc.
1 Recall on Record
Plain English
Edarbi is a tablet containing azilsartan kamedoxomil at 40 mg/1, taken oral. Manufactured by Azurity Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Edarbi
- Generic Name
- Azilsartan kamedoxomil
- NDC Code (Product)
60631-040- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Strength
- 40 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA200796
- Marketing Start
- 02/01/2013
Recall History
1 Recall on Record
Class II03/15/2021
Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
TerminatedVoluntary: Firm initiated
Frequently Asked Questions
What is Edarbi used for?
Edarbi contains Azilsartan kamedoxomil. It is a tablet taken oral. Consult your doctor for specific uses.
Is Edarbi a controlled substance?
Edarbi is not classified as a controlled substance by the DEA.
What is the generic name for Edarbi?
The generic name for Edarbi is Azilsartan kamedoxomil. There are 5 other brand versions of Azilsartan kamedoxomil.
What is the NDC code for Edarbi 40 mg/1?
The NDC (National Drug Code) for Edarbi 40 mg/1 is 60631-040, listed by Azurity Pharmaceuticals, Inc..